
Suzanne Jin
151 posts

Suzanne Jin
@suzannejin
PhD Bioinformatics @ CRG | Bio x AI is the next move | Current status: processing random thoughts 🤖🧬🍲🎨🐈⬛✨








We're officially releasing the Adaptyv API, which gives you and your AI agents access to our wet-lab to test your proteins experimentally! • Check out our demo and the docs here: agents.adaptyvbio.com • Check out how our partners @tamarindbio and @phylo_bio have integrated the Adaptyv API into their platforms We started Adaptyv with the idea that anyone should be able to test a designed protein, whether they have their own lab or not. Over the past three years we've tested tens of thousands of proteins from pharmas, AI for protein design companies, academic labs, alongside dozens of early-stage startups and individual researchers. Until now, all of that went through our Foundry portal or also email threads and Slack channels. We think the process of testing a designed protein should be as simple as calling an endpoint, so we built an API around the same infrastructure those teams already use, to make everything as accessible as possible. As AI agents will do more and more scientific work, it's important to give them the tools to access real-world experimental validation. To put it simply: AI can think but it cannot touch - we're giving AI access to the lab to validate experimental hypotheses.

I kept getting distracting while vibe coding… so I made a notch for Claude Code It updates the status, pings you when you need to answer a question and notifies you when the task is done When it detects claude is working it also prevents my macbook from going to sleep I can walk away from my macbook. Or watching a youtube video. And I'll get an alert when it's done.




I want it












Our paper on variational synthesis is out now in Nature Biotechnology. Manufacturing-aware generative models — AI architectures that know how to physically build their own designs — enabling synthesis of DNA encoding ~10^16 AI-designed proteins at a cost that would be roughly a quadrillion dollars using conventional methods.




